BL 1831
Alternative Names: AclinoxLatest Information Update: 18 Nov 2003
At a glance
- Originator Bioglan Pharma [CEASED]
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 09 Nov 2000 Preregistration for Acne in European Union (Unknown route)